Form 4 for ANIK Anika Therapeutics, Inc.
Accepted 2025-06-05 00:00:00 ET · period of report 2025-06-03 · accession 0001171843-25-003729 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-05 | 2025-06-03 | ANIK | Griffin Stephen D. | EVP, CFO, COO | M - OptEx | $0.00 | +12.8K | 13.6K | +1,605% | $0 |
| D | 2025-06-05 | 2025-06-03 | ANIK | Griffin Stephen D. | EVP, CFO, COO | F - Tax | $11.59 | -3,769 | 9,871 | -28% | -$43.7K |
| D | 2025-06-05 | 2025-06-03 | ANIK | Griffin Stephen D. | EVP, CFO, COO | M - OptEx | $0.00 | +12.8K | 25.7K | +100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-03 | M | A | 12,840 | $0.00 | 13,640 | D | — | — | (F1) Reflects the first vesting installment of RSUs granted on June 3, 2024. (F2) Includes 800 shares acquired on May 14, 2025 under the Anika Therapeutics, Inc. Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2025-06-03 | F | D | 3,769 | $11.59 | 9,871 | D | — | — | (F3) Reflects an aggregate of 3,769 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on June 3, 2025. (F4) Reflects the closing price of ANIK common stock on June 3, 2025, the trading date on which the vesting of RSUs gave rise to tax withholding obligations. |
| 3 | Derivative | Restricted Stock Unit | 2025-06-03 | M | A | 12,840 | $0.00 | 25,680 | D | $0.00 · — to — | 12,840 Common Stock | (F5) Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning June 3, 2025. |